Home >> Signaling Pathways >> Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Products for  Immunology/Inflammation

  1. Cat.No. 产品名称 Information
  2. GC50374 TH 1020 TH 1020是一种Toll样受体5(TLR5)/鞭毛蛋白复合物拮抗剂,IC50值为0.85μM。
  3. GC50356 CL 075

    2-丙基噻唑并[4,5-C]喹啉-4-胺,3M002

    CL 075 (3M002) 是一种具有免疫调节特性的选择性 TLR8 激动剂。
  4. GC50350 TC JL 37 TC JL 37 是一种有效的、选择性的、可口服的 TYK2 抑制剂,Ki 为 1.6 nM。
  5. GC50342 CP 424174 An inhibitor of stimulus-coupled IL-1β post-translational processing
  6. GC50297 RS 09 RS 09是一种能够激活TLR-4信号通路的合成肽。RS 09可以作为佐剂增强BALB/c小鼠的免疫反应。
  7. GC50296 D9

    D9 是一种有效的选择性硫氧还蛋白还原酶 (TrxR) 抑制剂,EC50 为 2.8 nM。 D9 具有在体外和体内抑制肿瘤增殖的能力。

  8. GC50292 c-Di-GMP sodium salt Endogenous STING and DDX41 agonist; activates STING-dependent signaling
  9. GC50280 JX 06

    NSC 402538

    An irreversible PDHK inhibitor
  10. GC50253 PF 543 hydrochloride

    Sphingosine Kinase 1 Inhibitor II hydrochloride

    A potent inhibitor of SPHK1
  11. GC50243 NFAT inhibitor, Cell Permeable A cell-permeable form of NFAT inhibitor
  12. GC50242 RA 839 RA 839 是 Keap1 的非共价小分子结合剂,Kd 约为 6 μM,是 Nrf2 信号传导的选择性激活剂。
  13. GC50241 M62812 TLR-4 inhibitor
  14. GC50238 PMX 53c Negative control for PMX 53
  15. GC50190 Fenretinide - d4

    4-HPR-d4, 4-Hydroxy(phenyl)retinamide-d4, Retinoic Acid p-hydroxyphenylamide-d4

    An internal standard for the quantification of fenretinide
  16. GC50176 PMX 53

    3D53

    PMX 53是一种高效且具有细胞渗透性和口服活性的C5a受体(CD88)拮抗剂,IC50值为20nM。
  17. GC50165 SM 324405 A TLR7 agonist
  18. GC50139 SP 100030 SP 100030 是一种有效的 NF-κB 和 activator protein-1 (AP-1) 双抑制剂(IC50s 分别为 50 和 50 nM)。
  19. GC50109 AZD 5582 dihydrochloride A Smac mimetic and IAP inhibitor
  20. GC50101 TFC 007 An H-PGDS inhibitor
  21. GC50093 MRT 68601 hydrochloride Potent TBK inhibitor
  22. GC50045 PD 166285 dihydrochloride

    6-(2,6-二氯苯基)-2-[[4-[2-(二乙基氨基)乙氧基]苯基]氨基]-8-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮盐酸盐

    A tyrosine kinase inhibitor
  23. GC50011 Nw-Propyl-L-arginine hydrochloride

    N-omega-Propyl-L-arginine hydrochloride

    Nω-Propyl-L-arginine (N-omega-Propyl-L-arginine) hydrochloride 是一种有效的、竞争性的、高度选择性的神经元一氧化氮合酶 (nNOS) 抑制剂,Ki 为 57 nM。
  24. GC50009 LY 294002 hydrochloride Prototypical PI 3-kinase inhibitor; also inhibits other kinases
  25. GC39311 YQ128 An NLRP3 inflammasome inhibitor
  26. GC39302 PARP14 inhibitor H10 PARP14 inhibitor H10 (化合物 H10) 是针对 PARP14 的选择性抑制剂 (IC50=490 nM),是其他 PARP 的抑制剂 (约为 PARP1 的 24 倍)。PARP14 抑制剂 H10 诱导 caspase-3/7 介导的细胞凋亡 (apoptosis)。
  27. GC39296 1G244 1G244 是一种有效的 DPP8/9 抑制剂,IC50 分别为 12 nM 和 84 nM,但不抑制 DPPIV 和 DPPII。1G244 可诱导多发性骨髓瘤细胞凋亡,并具有抗骨髓瘤作用。
  28. GC39295 DJ001 DJ001 是一种高度特异性,选择性和非竞争性的蛋白酪氨酸磷酸酶-σ (PTPσ) 抑制剂,IC50 为 1.43 μM。DJ001 对其他磷酸酶无抑制活性,对蛋白质磷酸酶 5 仅有中等抑制活性。DJ001 促进造血干细胞再生。
  29. GC39285 CU-T12-9 CU-T12-9是一种特异性Toll样受体TLR1/TLR2异二聚体的小分子激动剂,其EC50为52.9nM,CU-T12-9通过促进TLR1和TLR2二聚化,进而激活NF-κB信号通路
  30. GC39284 ANI-7 ANI-7 是一种 AhR 途径的激活剂。ANI-7 抑制多种癌细胞的生长,并有选择地抑制 MCF-7 乳腺癌细胞的生长,GI50 为 0.56 μM。ANI-7 通过激活 AhR 途径诱导 CYP1 代谢单加氧酶,并在敏感的乳腺癌细胞系中诱导 DNA 损伤,检查点激酶 (Chk2) 激活,S 期细胞周期停滞和细胞死亡。
  31. GC39281 (R)-CR8 trihydrochloride

    CR8, (R)-Isomer trihydrochloride

    An inhibitor of cyclin-dependent kinases
  32. GC39280 B022

    4-(1-(2-氨基-5-氯嘧啶-4-基)-2-(噻唑-2-基)-3-丁炔-2-醇

    B022是一种强效且选择性的NF-κB-inducing kinase (NIK)抑制剂,IC50值为15.1nM。
  33. GC39271 (±)-Naringenin

    (±)-柚皮素

    A citrus-derived flavonoid
  34. GC39266 Hematein

    氧化苏木精

    Hematein inhibits casein kinase II activity in a selective, dose-dependent and ATP non-competitive manner in vitro, with IC50 of 0.55 μM in the presence of 10 μM ATP.
  35. GC39254 Anatabine dicitrate

    柠檬酸新烟草碱

    Anatabine dicitrate 是一种烟草生物碱,可以穿过血脑屏障。Anatabine dicitrate 是一种有效的 α4β2 nAChR 激动剂。Anatabine dicitrate 通过阻止淀粉样蛋白前体蛋白的 β 裂解,抑制 NF-κB 激活,并降低淀粉样 β (Aβ) 的产生。Anatabine dicitrate 具有抗炎作用,可用于神经退行性疾病的研究。
  36. GC39239 Rifamycin S

    利福霉素S

    Rifamycin S, a quinone and an antibiotic against Gram-positive bacteria (including MRSA), is a clinical drug used to treat tuberculosis and leprosy. Rifamycin S generates reactive oxygen species (ROS) and inhibits microsomal lipid peroxidation.
  37. GC39232 Valepotriate

    戊曲酯,Valtrate

    A valepotriate with diverse biological activities
  38. GC39209 LCH-7749944

    GNF-PF-2356

    LCH-7749944 (GNF-PF-2356) is a novel and potent p21-activated kinase 4 (PAK4) inhibitor with an IC50 of 14.93 μM and has less potently inhibitory effect against PAK1, PAK5 and PAK6. LCH-7749944 causes successful inhibition of EGFR activity due to its inhibitory effect on PAK4.
  39. GC46238 Yatein

    亚太因

    A lignan with diverse biological activities
  40. GC46232 Tiamulin-d10 (hydrochloride)

    泰妙菌素盐酸盐-D10

    An internal standard for the quantification of tiamulin
  41. GC46228 Streptimidone

    链米酮

    A bacterial metabolite with diverse biological activities
  42. GC46227 STING18 A competitive STING ligand
  43. GC46226 SS-208 An HDAC6 inhibitor
  44. GC46223 Sparsomycin

    司帕索霉素

    A bacterial metabolite with diverse biological activities
  45. GC46222 SLM6031434 (hydrochloride) An SPHK2 inhibitor
  46. GC46221 Seselin

    邪蒿素

    An angular pyranocoumarin with diverse biological activities
  47. GC46219 Satratoxin H A trichothecene mycotoxin
  48. GC46216 Salazinic Acid

    水杨嗪酸

    A depsidone lichen metabolite
  49. GC46215 S-Acetyl-L-glutathione

    S-乙酰-L-谷胱甘肽

    A derivative of glutathione
  50. GC46214 Roccellic Acid

    石蕊酸

    A lichen secondary metabolite
  51. GC46198 Penicinoline An alkaloid

Items 2301 to 2350 of 4243 total

per page

Set Descending Direction